Search


	Podcast:		OncLive® On Air
	Episode:		18: FDA Approval Insights: Ramucirumab/Erlotinib in EGFR+ Metastatic NSCLC
	Category:		Science & Medicine
	Duration:		00:18:01
	Publish Date:		2020-07-06 12:23:11
	Description:		In our exclusive interview, Edgardo S. Santos, MD, discusses the data that led to the approval of ramucirumab in combination with erlotinib and shares his thoughts on its utility in the frontline setting.
	Total Play:		0